United States of Ozempic; Where Anti-Obesity Drugs Are Taking Off
January 19, 2024

(Axios) – For every 1,000 people in Kentucky, roughly 21 were prescribed a drug that belongs to a buzzy class of diabetes and anti-obesity medications last year — the highest rate of any state, according to insurance claims data provided to Axios by health analytics company PurpleLab. The big picture: It’s among a few Southern states, including Louisiana and Mississippi, that had some of the highest prescribing rates for drugs like Ozempic and Wegovy. (Read More)